You are currently viewing a new version of our website. To view the old version click .

Immuno, Volume 1, Issue 3

September 2021 - 14 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Review
  • Open Access
6 Citations
10,547 Views
28 Pages

Role of KIR Receptor in NK Regulation during Viral Infections

  • Sabrina Rizzo,
  • Giovanna Schiuma,
  • Silvia Beltrami,
  • Valentina Gentili,
  • Roberta Rizzo and
  • Daria Bortolotti

6 September 2021

Natural Killer (NK) cells are key effectors of the innate immune system which represent the first line of defense against viral infections. NK cell activation depends on the engagement of a complex receptor repertoire expressed on their surface, cons...

  • Review
  • Open Access
2 Citations
4,711 Views
20 Pages

Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19

  • Niraj Kumar Jha,
  • Charu Sharma,
  • Mohamed Fizur Nagoor Meeran,
  • Saurabh Kumar Jha,
  • Vivek Dhar Dwivedi,
  • Piyush Kumar Gupta,
  • Abhijit Dey,
  • Kavindra Kumar Kesari and
  • Shreesh Ojha

30 August 2021

The COVID-19 pandemic, caused by SARS-CoV-2, is a deadly disease affecting millions due to the non-availability of drugs and vaccines. The majority of COVID-19 drugs have been repurposed based on antiviral, immunomodulatory, and antibiotic potential....

  • Article
  • Open Access
2 Citations
2,458 Views
8 Pages

Age-Associated Characteristics of CD4+ T-Cell Composition in Patients with Atherosclerosis

  • Anastasiia Yu. Filatova,
  • Alexandra V. Potekhina and
  • Tatiana I. Arefieva

27 August 2021

Background. We aimed to analyze the contents of the main CD4+ T-cell subsets in patients with atherosclerosis (AS) depending on age. Methods. Male patients with coronary and/or carotid AS, who are non-smokers, and who are receiving statins were divid...

  • Article
  • Open Access
4 Citations
4,334 Views
13 Pages

Banana Lectin from Musa paradisiaca Is Mitogenic for Cow and Pig PBMC via IL-2 Pathway and ELF1

  • Roxane L. Degroote,
  • Lucia Korbonits,
  • Franziska Stetter,
  • Kristina J. H. Kleinwort,
  • Marie-Christin Schilloks,
  • Barbara Amann,
  • Sieglinde Hirmer,
  • Stefanie M. Hauck and
  • Cornelia A. Deeg

26 August 2021

The aim of the study was to gain deeper insights in the potential of polyclonal stimulation of PBMC with banana lectin (BanLec) from Musa paradisiaca. BanLec induced a marked proliferative response in cow and pig PBMC, but was strongest in pigs, wher...

  • Article
  • Open Access
18 Citations
5,145 Views
11 Pages

Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients

  • Elisa Giommoni,
  • Roberta Giorgione,
  • Agnese Paderi,
  • Elisa Pellegrini,
  • Elisabetta Gambale,
  • Andrea Marini,
  • Andrea Antonuzzo,
  • Riccardo Marconcini,
  • Giandomenico Roviello and
  • Marco Matucci-Cerinic
  • + 3 authors

17 August 2021

Background: To date, no biomarkers are effective in predicting the risk of developing immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICIs). This study aims to evaluate the association between basal absolu...

  • Article
  • Open Access
1 Citations
3,556 Views
13 Pages

A Functional GM-CSF Receptor on Dendritic Cells Is Required for Efficient Protective Anti-Tumor Immunity

  • Emily Charrier,
  • Rémi Vernet,
  • Frank Schwenter,
  • Patricia Luy,
  • Alena Donda and
  • Nicolas Mach

6 August 2021

Dendritic cells (DC) play a major role during the priming phase of anti-tumor immunization, as they are required for an efficient tumor-associated antigens presentation. At least one dendritic cell-based therapy has already been successfully approved...

  • Review
  • Open Access
3 Citations
4,354 Views
8 Pages

Anti-Cancer Immune Reaction and Lymph Node Macrophage; A Review from Human and Animal Studies

  • Yoshihiro Komohara,
  • Toshiki Anami,
  • Kenichi Asano,
  • Yukio Fujiwara,
  • Junji Yatsuda and
  • Tomomi Kamba

15 July 2021

Lymph nodes are secondary lymphoid organs that appear as bean-like nodules usually <1 cm in size, and they are localized throughout the body. Many antigen-presenting cells such as dendritic cells and macrophages reside in lymph nodes, where they m...

  • Article
  • Open Access
12 Citations
5,240 Views
11 Pages

12 July 2021

The increased prevalence of neurodegenerative diseases, especially during the COVID-19 outbreak, necessitates the search for natural immune- and cognitive-enhancing agents. 10-Hydroxy-trans-2-decenoic acid (10-H2DA), the main fatty acid of royal jell...

  • Review
  • Open Access
18 Citations
16,168 Views
18 Pages

ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

  • Thomas Morgan Hulen,
  • Christopher Aled Chamberlain,
  • Inge Marie Svane and
  • Özcan Met

9 July 2021

The past decades of cancer immunotherapy research have provided profound evidence that the immune system is capable of inducing durable tumor regression. Although many commercialized anti-cancer immunotherapies are available to patients, these treatm...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Immuno - ISSN 2673-5601